Company: BACC
Filing Date: 2025-05-14
Form Type: S-1
Source: 0001185185-25-000465
Chunk: 261

Company: Blue Acquisition Corp/Cayman
Filing Date: 2025-05-14
Form: S-1
Chunk 261
---
egotiated transactions (as described in this prospectus), if any, could result in the approval of our
initial business combination even if a majority of our public shareholders vote, or indicate their intention to vote, against such initial
business combination. For purposes of seeking approval of an ordinary resolution, non-votes will have no effect on the approval of our
initial business combination once a quorum is obtained. Our amended and restated memorandum and articles of association require that at
least five clear days’ notice will be given of any general meeting.

If we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our amended and restated memorandum and articles of association provide that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Exchange Act), will be restricted from redeeming its shares with respect to Excess Shares without our prior consent. However, we would not be restricting our shareholders’ ability to vote all of their shares (including Excess Shares) for or against our initial business combination. Our shareholders’ inability to redeem the Excess Shares will reduce their influence over our ability to complete our initial business combination, and such shareholders could suffer a material loss in their investment if they sell such Excess Shares on the open market. Additionally, such shareholders will not receive redemption distributions with respect to the Excess Shares if we complete our initial business combination. And, as a result, such shareholders will continue to hold that number of shares exceeding 15% and, in order to dispose such shares would be required to sell their shares in open market transactions, potentially at a loss.

If we seek shareholder approval in connection with
our initial business combination, our sponsor, officers and directors have agreed to vote their founder shares, private placement shares
and any public shares purchased during or after this offering (including in open market and privately-negotiated transactions, aside from
shares they may purchase in compliance with the requirements of Rule 14e-5 under the Exchange Act, which would not be voted
in favor of approving the business combination transaction) in favor of our initial business combination. As a result, if all outstanding
shares are voted on a resolution to approve our initial business combination, in addition to our 5,269,500 initial shareholders’
founder shares and 340,000 private placement shares, if we would